Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
25.08
+0.17 (0.68%)
Jun 4, 2025, 1:43 PM - Market open

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $3.06 billion as of June 4, 2025. Its market cap has increased by 57.92% in one year.

Market Cap
3.06B
Enterprise Value
2.46B
1-Year Change
57.92%
Ranking
Category
Stock Price
$25.08

Market Cap Chart

Since December 15, 2006, Catalyst Pharmaceuticals's market cap has increased from $69.00M to $3.06B, an increase of 4,333.53%. That is a compound annual growth rate of 22.78%.

History

DateMarket Cap% Change
Jun 3, 20253.04B22.06%
Dec 31, 20242.49B38.90%
Dec 29, 20231.79B-7.42%
Dec 30, 20221.94B177.28%
Dec 31, 2021698.10M101.65%
Dec 31, 2020346.20M-10.40%
Dec 31, 2019386.40M95.84%
Dec 31, 2018197.30M-40.80%
Dec 29, 2017333.30M283.10%
Dec 30, 201687.00M-57.12%
Dec 31, 2015202.90M-1.17%
Dec 31, 2014205.30M94.41%
Dec 31, 2013105.60M599.34%
Dec 31, 201215.10M-52.66%
Dec 30, 201131.90M66.15%
Dec 31, 201019.20M68.42%
Dec 31, 200911.40M-54.94%
Dec 31, 200825.30M-41.44%
Dec 31, 200743.20M-28.60%
Dec 29, 200660.50M-12.32%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 662.23B
Johnson & Johnson 373.45B
AbbVie 328.75B
Novo Nordisk 305.07B
UnitedHealth Group 273.87B
Abbott Laboratories 232.41B
AstraZeneca 224.00B
Novartis AG 223.92B
Market Cap Rankings